封面
市场调查报告书
商品编码
1446459

颅内动脉瘤市场规模、份额、趋势分析报告:按类型、最终用途、按地区、细分市场趋势:2024-2030

Intracranial Aneurysm Market Size, Share & Trends Analysis Report By Type, (Surgical Clipping, Endovascular Coiling, Flow Diverters), By End-use, By Region, And Segment Forecasts, 2024 - 2030

出版日期: | 出版商: Grand View Research | 英文 137 Pages | 商品交期: 2-10个工作天内

价格

颅内动脉瘤市场成长与趋势:

Grand View Research, Inc.最新报告显示,预计到2030年,全球颅内动脉瘤市场规模将达到23.3亿美元,2023年至2030年复合年增长率为9.08%。

市场的成长归因于多种因素,例如中风病例增加、脑血管意外发病率增加以及主要企业不断推出产品。它在新兴市场也迅速成长,这些市场的可支配收入水准有所提高,获得医疗保健的机会也有所改善。目前,脑动脉瘤的病因尚不清楚。然而,与这种情况相关的因素有很多,包括老龄化、脑外伤、遗传、高血压、动脉硬化、感染疾病和久坐的生活方式。显着的症状包括脑神经功能障碍、局部头痛和复视。

因此,受颅内动脉瘤影响的人数不断增加,促进了市场的扩张。该领域的公司不断寻找让现有治疗方法更安全、更有效的方法,同时引入新技术,这将增加全球对颅内动脉瘤产品的需求,这是可预期的。例如,2022年6月,印度美敦力公司开发了具有CE标誌的第四代流路偏转器“Pipeline Vantage with Shield Technology”,用于脑动脉瘤的血管内治疗。 Pipeline Vantage是一种新开发的导流器,配备了屏蔽技术,增强了输送系统和植入的设计特性。透过开发一种促进目标血管最内层细胞发育的支架,我们将使医生更容易、更可靠地输送、部署和修復脑动脉瘤和颅内动脉瘤。

颅内动脉瘤市场报告亮点

  • 2023年,血管内卷取圈占据市场主导地位,份额为84.6%。这是由于它在微创神经外科中的应用不断增加,并且可以轻鬆访问偏远地区的多个动脉瘤。
  • 2023年,医院终端用途细分收益占有率最大,为89.52%。颅内动脉瘤手术是最复杂的手术之一,依赖医院提供的高品质和耐用的设备。
  • 北美在2023年占据市场主导地位,份额为26.65%。该市场竞争激烈,现有企业和新兴企业都寻求透过产品创新、併购、收购和合作来获得行业份额。
  • 因此,北美主要企业的存在预计将推动该地区的市场成长。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章颅内动脉瘤市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 颅内动脉瘤市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • 价格分析

第四章颅内动脉瘤市场:类型估计和趋势分析

  • 类型市场占有率,2023 年和 2030 年
  • 细分仪表板
  • 按类型分類的全球颅内动脉瘤市场展望
  • 2018年至2030年市场规模、预测与趋势分析
    • 脑动脉夹闭术
    • 弹簧圈栓塞
    • 分流器
    • 其他的

第五章颅内动脉瘤市场:最终用途估计与趋势分析

  • 2023 年及 2030 年最终用途市场占有率
  • 细分仪表板
  • 以最终用途分類的全球颅内动脉瘤市场展望
  • 2018年至2030年市场规模、预测与趋势分析
    • 医院
    • 诊所
    • 其他的

第六章颅内动脉瘤市场:区域估计与趋势分析

  • 2023 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概况
  • 2018-2030年市场规模及预测趋势分析:
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商形势
    • List of key distributors and channel partners
    • Key customers
    • Key company market share analysis, 2023
    • Medtronic plc
    • Stryker Corporation
    • MicroPort Scientific Corporation.
    • Johnson &Johnson Services, Inc.
    • MicroVention Inc.
    • B. Braun Melsungen AG
    • Integra LifeSciences
    • RAUMEDIC AG
    • Terumo Corporation
    • Delta Surgical
Product Code: GVR-4-68038-416-1

Intracranial Aneurysm Market Growth & Trends:

The global intracranial aneurysm market size is anticipated to reach USD 2.33 billion by 2030, registering a CAGR of 9.08% from 2023 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is attributed to various factors, such as increased cases of stroke, increasing incidence of people suffering from cerebrovascular disorders, and continuous product launches by key players. Furthermore, the market is growing rapidly in developing nations with expanding disposable income levels and improved access to healthcare. Currently, the cause of brain aneurysms is not clearly understood. However, there are various factors linked to this condition, including aging, brain trauma, hereditary, high blood pressure, atherosclerosis, infections, and a sedentary lifestyle. Notable symptoms encompass cranial nerve dysfunction, localized headaches, and double vision.

Consequently, the growing population of individuals afflicted with intracranial aneurysms is contributing to the market expansion. Businesses in this field are always looking for ways to make existing therapies safer and more effective while also introducing new technologies, which are anticipated to increase the demand for intracranial aneurysm products globally. For instance, in June 2022, Pipeline Vantage with Shield Technology, a fourth-generation flow deflector with a CE mark by India Medtronic, was developed for endovascular therapy for cerebral aneurysms. A newly developed flow deflector, Pipeline Vantage, features Shield technology and has enhanced features of the design for both the delivery system and the implant. By developing a scaffold that promotes the development of cells in the innermost layer of the target blood vessel, these qualities make it easier and more reliable for doctors to deliver, deploy, and repair brain aneurysms and intracranial aneurysms.

Intracranial Aneurysm Market Report Highlights:

  • In 2023, the endovascular coiling segment dominated the market with a share of 84.6%due to its increasing application in minimally invasive neurosurgeries and easy access to multiple aneurysms in distant areas
  • The hospitals end-use segment held the largest revenue share of 89.52% in 2023. Intracranial aneurysm procedures are among the most complicated surgeries that are dependent on high-quality and durable equipment available in hospitals
  • North America dominated the market with a share of 26.65% in 2023. The market is competitive, with both established companies and emerging players striving to capture higher industry share through product innovations, mergers, acquisitions, and partnerships
  • Thus, the presence of key players in North America is expected to boost the regional market growth

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. End-use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type
    • 2.2.2. End-use
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Intracranial aneurysm Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing incidence of neurological diseases
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Increasing preference for targeted therapy approach
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Risk of DBS surgery
      • 3.2.2.2. Complex regulatory framework
  • 3.3. Intracranial aneurysm Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
      • 3.3.2.4. Pricing Analysis
    • 3.3.3. Pricing Analysis

Chapter 4. Intracranial aneurysm Market: Type Estimates & Trend Analysis

  • 4.1. Type Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Intracranial aneurysm Market by Type Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Surgical Clipping
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Endovascular Coiling
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Flow Diverters
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Intracranial aneurysm Market: End-use Estimates & Trend Analysis

  • 5.1. End-use Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Intracranial aneurysm Market by End-use Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Hospitals
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 5.4.2. Clinics
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Others
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Intracranial aneurysm Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/ reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/ reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework/ reimbursement structure
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework/ reimbursement structure
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework/ reimbursement structure
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Mexico
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.3. Argentina
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework/ reimbursement structure
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework/ reimbursement structure
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework/ reimbursement structure
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework/ reimbursement structure
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework/ reimbursement structure
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Medtronic plc
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Type benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Stryker Corporation
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Type benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. MicroPort Scientific Corporation.
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Type benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Johnson & Johnson Services, Inc.
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Type benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. MicroVention Inc.
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Type benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. B. Braun Melsungen AG
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Type benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Integra LifeSciences
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Type benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. RAUMEDIC AG
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Type benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Terumo Corporation
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Type benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. Delta Surgical
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Type benchmarking
      • 7.3.13.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Intracranial aneurysm market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 4 North America Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 5 U.S. Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 6 U.S. Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 Canada Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 8 Canada Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Europe Intracranial aneurysm market, by region, 2018 - 2030 (USD Million)
  • Table 10 Europe Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 11 Europe Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Germany Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 13 Germany Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 UK Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 15 UK Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 France Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 17 France Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 Italy Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 19 Italy Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Spain Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 21 Spain Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 Denmark Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 23 Denmark Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Sweden Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 25 Sweden Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 Norway Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 27 Norway Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific Intracranial aneurysm market, by region, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 China Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 32 China Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 Japan Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 34 Japan Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 India Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 36 India Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 South Korea Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 38 South Korea Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 Australia Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 40 Australia Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Thailand Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 42 Thailand Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Latin America Intracranial aneurysm market, by region, 2018 - 2030 (USD Million)
  • Table 44 Latin America Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 45 Latin America Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 46 Brazil Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 47 Brazil Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Mexico Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 49 Mexico Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Argentina Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 51 Argentina Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 MEA Intracranial aneurysm market, by region, 2018 - 2030 (USD Million)
  • Table 53 MEA Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 54 MEA Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 55 South Africa Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 56 South Africa Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 UAE Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 60 UAE Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait Intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
  • Table 62 Kuwait Intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Intracranial aneurysm market: market outlook
  • Fig. 14 Intracranial aneurysm competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Intracranial aneurysm market driver impact
  • Fig. 20 Intracranial aneurysm market restraint impact
  • Fig. 21 Intracranial aneurysm market strategic initiatives analysis
  • Fig. 22 Intracranial aneurysm market: Type movement analysis
  • Fig. 23 Intracranial aneurysm market: Type outlook and key takeaways
  • Fig. 24 Surgical Clipping market estimates and forecast, 2018 - 2030
  • Fig. 25 Endovascular Coiling market estimates and forecast, 2018 - 2030
  • Fig. 26 Flow Diverters market estimates and forecast, 2018 - 2030
  • Fig. 27 Others market estimates and forecast, 2018 - 2030
  • Fig. 28 Intracranial aneurysm market: End-use movement analysis
  • Fig. 29 Intracranial aneurysm market: End-use outlook and key takeaways
  • Fig. 30 Hospitals market estimates and forecasts, 2018 - 2030
  • Fig. 31 Clinics market estimates and forecasts,2018 - 2030
  • Fig. 32 Others market estimates and forecasts,2018 - 2030
  • Fig. 33 Global Intracranial aneurysm market: Regional movement analysis
  • Fig. 34 Global Intracranial aneurysm market: Regional outlook and key takeaways
  • Fig. 35 Global Intracranial aneurysm market share and leading players
  • Fig. 36 North America market share and leading players
  • Fig. 37 Europe market share and leading players
  • Fig. 38 Asia Pacific market share and leading players
  • Fig. 39 Latin America market share and leading players
  • Fig. 40 Middle East & Africa market share and leading players
  • Fig. 41 North America market estimates and forecasts, 2018 - 2030
  • Fig. 42 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 43 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 44 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 45 UK market estimates and forecasts, 2018 - 2030
  • Fig. 46 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 47 France market estimates and forecasts, 2018 - 2030
  • Fig. 48 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 49 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 50 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 51 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 52 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 53 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 54 China market estimates and forecasts, 2018 - 2030
  • Fig. 55 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 56 India market estimates and forecasts, 2018 - 2030
  • Fig. 57 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 58 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 59 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 60 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 61 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 62 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 63 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 64 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 65 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 66 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 67 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 68 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 69 Market share of key market players- Intracranial aneurysm market